IOL Chemicals & Pharmaceuticals Limited is an innovation-driven bulk drug, intermediates, and specialty chemicals company, built on a prolific history of progress and expansion over three decades. They are strategically expanding their product portfolio with a pipeline of new products that will form a strong foundation for future growth. They are an API-based pharmaceutical company, with substantive manufacturing capacities that lend economies of scale and cost supremacy. They also have extensive expertise in specialty chemicals, which provides a foundation for diversified growth opportunities and strengthens their business model. Their APIs portfolio covers various therapeutic categories, such as pain management, anti-diabetic, anti-hypertensive, and anti-convulsant, amongst others. They are the only backward integrated company producing all intermediates and key starting materials (KSMs) of ibuprofen.